Royal Marsden Nhs Foundation Trust

This early-stage study tested a new drug, CCT3833, in 31 adults with advanced solid tumors, including melanoma. The main goal was to find a safe dose and understand side effects. Researchers also looked at how the drug moves through the body. This is not a cure, but a step toward…

This early-phase study tested an experimental drug called VS-6766, given by mouth on different schedules, in 104 adults with advanced solid tumors or multiple myeloma. The goal was to find a safe and tolerable dose, both when used alone and when combined with another drug (everol…